Goldstein, Elizabeth A.; Ruscio, John
May 2009
Scientific Review of Mental Health Practice;2009, Vol. 7 Issue 1, p3
Academic Journal
The Food and Drug Administration issued a black box warning in response to concerns that antidepressants may increase the risk or suicidality in children and young adults. In the effort to weigh the benefits and risks of anti-depressants, numerous methodological challenges preclude the determination of a definitive answer. The available empirical findings and mixed, with some studies displaying an association between antidepressant use and reduced suicidality, and other studies uncovering a significant risk of suicidality for patients treated with antidepressants compared to placebo. In the absence of more conclusive information regarding the relative safety and efficacy of antidepressant medication, frequent monitoring, especially during the first weeks of treatment, should be a component of all treatment plans. Further research is needed to determine which patients might benefit most from antidepressant treatment, as well as whether the black box warning has prevented suicide, or merely hindered the prescription of potentially helpful medication.


Related Articles

  • Unintended Consequences of FDA Antidepressant Warnings. Sussman, Norman // Primary Psychiatry;Sep2009, Vol. 16 Issue 9, p14 

    The author talks about the consequences resulting from the antidepressant warnings issued by the U.S. Food and Drug Administration (FDA). The warnings concern the risk of suicide among all age groups who are administered with antidepressants. He discusses two studies, the first of which states...

  • Trouble in a 'Black Box' Dokoupil, Tony // Newsweek (Atlantic Edition);7/16/2007 (Atlantic Edition), Vol. 150 Issue 3, p50 

    This article explores the relationship between the decrease in prescriptions for selective serotonin reuptake inhibitors (SSRIs) and the increase in the rate of teenage suicides. The U.S. Food and Drug Administration warned that there was a link between the intake of SSRI antidepressants and...

  • Black box warnings to be added to all antidepressants.  // Drug Topics;10/25/2004, Vol. 148 Issue 20, p8 

    This article reports that a Public Health Advisory has been issued by the U.S. Food and Drug Administration announcing its multi-pronged strategy to warn the public about the increased risk of suicidality in children and adolescents being treated with antidepressant medications. The agency is...

  • Antidepressants for children with depression. HONGSANGUANSRI, Sirichai // Shanghai Archives of Psychiatry;Jun2013, Vol. 25 Issue 3, p195 

    The article focuses on the effectiveness of antidepressants for children experiencing depression in the U.S. It mentions how the warning released by the U.S. Food and Drug Administration (FDA) regarding the suicide risk of children using antidepressant decrease the number of reported cases in...

  • US FDA calls for antidepressant 'black box' update.  // Reactions Weekly;5/12/2007, Issue 1151, p3 

    The article focuses on a proposal from the U.S. Food and Drug Administration that all manufacturers of antidepressants update the existing black box warning. The agency proposed the inclusion of a warning about increased risks of suicidal thinking and behavior in young adults during the initial...

  • Antidepressants' Black Box Warning: Doing More Harm than Good?  // Journal of Psychosocial Nursing & Mental Health Services;Feb2007, Vol. 45 Issue 2, p10 

    The article offers information on "black box" warnings issued by the U.S. Food and Drug Administration (FDA) about the increase in suicide risk among children receiving antidepressant agents. A proposal endorsed by the advisory panel of the FDA during the December 13, 2006 hearing on adult...

  • THE BEST MEDICINE. Wingert, Pat // Newsweek;9/27/2004, Vol. 144 Issue 13, p88 

    Reports that the U.S. Food and Drug Administration panel advised adding warnings to antidepressants because they cause two to three percent of children to become suicidal. Risks of not treating depressed children; Views of National Institutes of Health researcher Dr. John March; Topic of...

  • Antidepressants triggering suicidal ideation: An area of concern. Rajgadhi, Himali; Gupta, Sapna; Malhotra, Supriya Deepak; Thakor, Advait; Patel, Pankaj // Indian Journal of Pharmacology;Nov/Dec2016, Vol. 48 Issue 6, p733 

    This is a report of four cases of possible suicidal ideation with the use of antidepressants in Indian population. The patients presented to emergency department of a tertiary care hospital with attempted suicide. All of them were prescribed at least one antidepressant. The association of...

  • Antidepressant Medications: A New Warning About Risks….  // Child Health Alert;Jun2007, Vol. 25, p3 

    The article reports on the decision of the U.S. Food & Drugs Administration to expand a warning that use of antidepressants might increase the risk of suicide or suicidal thinking. A published analysis of this action notes that it is hard to know whether suicide is caused by taking the drug or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics